BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25736311)

  • 41. TCL1 expression predicts overall survival in patients with mantle cell lymphoma.
    Shin SJ; Roh J; Cha HJ; Choi YD; Kim JM; Min SK; Kim JE; Eom DW; Lee H; Kim HJ; Yoon DH; Suh C; Huh J
    Eur J Haematol; 2015 Dec; 95(6):583-94. PubMed ID: 25688912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mantle Cell Lymphoma Under the Scope of Personalized Medicine: Perspective and Directions.
    Gallucci Figorelle L; Galvão PT; de Lima FMR; Marimon P; Pentagna N; Milito C; Schaffel R; Carneiro K
    Clin Lymphoma Myeloma Leuk; 2024 Jul; 24(7):433-445. PubMed ID: 38641485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages.
    Koh YW; Shin SJ; Park C; Yoon DH; Suh C; Huh J
    Hematol Oncol; 2014 Dec; 32(4):178-86. PubMed ID: 24910369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.
    Rao E; Jiang C; Ji M; Huang X; Iqbal J; Lenz G; Wright G; Staudt LM; Zhao Y; McKeithan TW; Chan WC; Fu K
    Leukemia; 2012 May; 26(5):1064-72. PubMed ID: 22116552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prognostic significance of miRNA-223 targeting SOX11 in mantle cell lymphoma].
    Zhang Q; Zhang WT; Wu SS; Yuan JJ; Tian L; Liu YY; Zuo WL; Song YP; Zhou KS
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):579-583. PubMed ID: 30122018
    [No Abstract]   [Full Text] [Related]  

  • 46. Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases.
    Veselá P; Tonar Z; Sálek D; Vokurka S; Trněný M; Kodet R; Moulis M; Kašparová P; Vernerová Z; Velenská Z; Stříteský J; Michal M; Boudová L
    Virchows Arch; 2014 Nov; 465(5):587-97. PubMed ID: 25048573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-150 inhibits proliferation of mantle-cell lymphoma cells via regulation of MET.
    Zhang WJ; Chen FF; Wang YQ; Yu W; Dong FL; Zhuang HX
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12063-12072. PubMed ID: 33336724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma.
    Yoo C; Yoon DH; Kim S; Huh J; Park CS; Park CJ; Lee SW; Suh C
    Hematol Oncol; 2016 Mar; 34(1):22-7. PubMed ID: 25689467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. microRNA-18b modulates insulin-like growth factor-1 expression in deer antler cell proliferation by directly targeting its 3' untranslated region.
    Hu W; Li M; Hu R; Li T; Meng X
    DNA Cell Biol; 2015 Apr; 34(4):282-9. PubMed ID: 25756952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
    Scheubeck G; Jiang L; Hermine O; Kluin-Nelemans HC; Schmidt C; Unterhalt M; Rosenwald A; Klapper W; Evangelista A; Ladetto M; Jerkeman M; Ferrero S; Dreyling M; Hoster E
    Leukemia; 2023 Sep; 37(9):1887-1894. PubMed ID: 37495776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of MiR101 and EZH2 in Patients with Mantle Cell Lymphoma and Its Clinical Significance].
    Lin YL; Zou ZK; Su HY; Huang YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):820-826. PubMed ID: 31204938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan.
    Chihara D; Asano N; Ohmachi K; Kinoshita T; Okamoto M; Maeda Y; Mizuno I; Matsue K; Uchida T; Nagai H; Nishikori M; Nakamura S; Ogura M; Suzuki R
    Br J Haematol; 2015 Sep; 170(5):657-68. PubMed ID: 25953436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
    Wang X; Sehgal L; Jain N; Khashab T; Mathur R; Samaniego F
    J Transl Med; 2016 Dec; 14(1):346. PubMed ID: 27998273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomic landscape and prognostic analysis of mantle cell lymphoma.
    Yang P; Zhang W; Wang J; Liu Y; An R; Jing H
    Cancer Gene Ther; 2018 Jun; 25(5-6):129-140. PubMed ID: 29755111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score.
    Salim R; Husby S; Winther Eskelund C; Scott DW; Holte H; Kolstad A; Räty R; Ek S; Jerkeman M; Geisler C; Sommer Kristensen L; Dahl M; Grønbæk K
    Leuk Lymphoma; 2023; 64(8):1414-1423. PubMed ID: 37259807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Yim RL; Wong KY; Kwong YL; Loong F; Leung CY; Chu R; Lam WW; Hui PK; Lai R; Chim CS
    Oncotarget; 2014 Oct; 5(20):9770-82. PubMed ID: 25211095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
    Le Bris Y; Magrangeas F; Moreau A; Chiron D; Guérin-Charbonnel C; Theisen O; Pichon O; Canioni D; Burroni B; Maisonneuve H; Thieblemont C; Oberic L; Gyan E; Pellat-Deceunynck C; Hermine O; Delfau-Larue MH; Tessoulin B; Béné MC; Minvielle S; Le Gouill S
    Hematol Oncol; 2020 Oct; 38(4):446-455. PubMed ID: 32472610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
    Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
    Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SOXC and MiR17-92 gene expression profiling defines two subgroups with different clinical outcome in mantle cell lymphoma.
    Roisman A; Huamán Garaicoa F; Metrebian F; Narbaitz M; Kohan D; García Rivello H; Fernandez I; Pavlovsky A; Pavlovsky M; Hernández L; Slavutsky I
    Genes Chromosomes Cancer; 2016 Jun; 55(6):531-40. PubMed ID: 26998831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.